How is DSIP administered?
This describes how DSIP is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, pre-bed, on a nightly schedule, generally over 2-4 weeks at a time. Specific dosing is individual and beyond general information, and human evidence for DSIP is limited.
Administration at a glance (reference data)
- Route: Subcutaneous, pre-bed
- Schedule: Nightly
- Cycle length: 2-4 weeks at a time
- Half-life: ~7 minutes (rapidly metabolized)
References
- Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia — Schneider-Helmert D. European Neurology, 1987
- Delta sleep-inducing peptide (DSIP): a still unresolved riddle — Kovalzon VM, Strekalova TV. Journal of Neurochemistry, 2006
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on DSIP
Last updated 2026-06-15.